VF
TELO icon

Virtu Financial’s Telomir Pharmaceuticals TELO Stock Holding History

Virtu Financial’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22K Buy
+17,546
New +$22.9K ﹤0.01% 1339
2026
Q1 		– Sell
-14,278
Closed -$19K – 2407
2025
Q4 		$19K Buy
+14,278
New +$20.6K ﹤0.01% 1439
2025
Q1 		– Sell
-14,959
Closed -$62K – 2143
2024
Q4 		$62K Buy
+14,959
New +$70.5K ﹤0.01% 1121

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return

Virtu Financial's TELO Position: Q2 2026 in Review

Virtu Financial opened a new position in Telomir Pharmaceuticals (TELO) in Q2 2026: 17,546 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #1339 among its holdings. This is a return to the name: Virtu Financial previously reported a position in TELO as recently as Q4 2025.

Virtu Financial first reported a position in TELO in Q4 2024 and has held it in 3 quarters since. The position peaked at $62K in Q4 2024. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • Virtu Financial held 17,546 shares of Telomir Pharmaceuticals worth $22K as of Q2 2026.
  • Telomir Pharmaceuticals was a new Virtu Financial position in Q2 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1339 holding.
  • Virtu Financial first reported a position in Telomir Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Virtu Financial's Telomir Pharmaceuticals position peaked at $62K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.